Company news

LeonaBio, Inc. news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

LeonaBio to Participate in Cantor Global Healthcare Conference 2026

September 3, 2026

LeonaBio to Highlight Lasofoxifene in ER-positive (ER+), HER2-negative, ESR1-mutated Metastatic Breast Cancer at DAVA Oncology’s 4th Summit on Breast Cancer

August 12, 2026

LeonaBio Presents on ATH-1105 at 5th Annual ALS Drug Development Summit

June 3, 2026

LeonaBio to Participate in Upcoming Medical and Industry Meetings in June

May 26, 2026

LeonaBio Enhances Board of Directors with Appointments of Fred Callori, J.D., Natalie Holles and Peter B. Silverman, J.D.

May 7, 2026

LeonaBio to Host Virtual Key Opinion Leader Event Highlighting Potential of Lasofoxifene in Treatment-Resistant ER+/HER2-, ESR1-Mutated Metastatic Breast Cancer

April 23, 2026

Independent Nonclinical Research on Lasofoxifene Presented at American Association for Cancer Research Annual Meeting 2026 Consistent with LeonaBio’s Data

April 21, 2026

LeonaBio Reports Full Year 2025 Financial Results and Provides Business Update

March 25, 2026

LeonaBio Appoints Industry Veteran Mark F. Kubik as Chief Business Officer

February 2, 2026

Athira Pharma Announces Reverse Stock Split

September 11, 2025

Decks

The 5 newest of 10 decks. Every deck is listed under its year.